Pavel V. Balakhnin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Pavel V. Balakhnin has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
- V. I. Malkevich
National Medical Research Center of Oncology n. a. N. N. Petrov, Ministry of Health of Russia
11 shared publications - Алексей Станиславович Шмелев
National Medical Research Center of Oncology n. a. N. N. Petrov, Ministry of Health of Russia
11 shared publications - Sergey Sergeevich Bagnenko
N. N. Petrov National Medical Research Center of Oncology; St. Petersburg State Pediatric Medical University
9 shared publications - Ivan A. Kurnosov
National Medical Research Center of Oncology n. a. N. N. Petrov, Ministry of Health of Russia
7 shared publications - Ksenia Vyacheslavovna Kozubova
ФГБУ «НМИЦ онкологии им. Н.Н. Петрова» МЗ РФ
7 shared publications - М.д. Ханевич
ФГБОУ ВО «Санкт-Петербургский государственный педиатрический медицинский университет» МЗ РФ
6 shared publications
Latest Publications
- Open Access
- 15 October 2026
- Published by "MedINK" Publishing House in Title
- Vol. 1 (1) , 8-40
New technologies of percutaneous cryoablation of tumors under the control of flat-detector computed tomography: Immediate and long-term results of treatment of 256 patients
Background . Previously, we developed and described two technologies for angiographically-assisted percutaneous argon-helium cryoablation (PCA) of metastatic liver tumors and kidney cancer using flat-detector computed tomography (FD–CT) for visualization, navigation, monitoring, and assessment of the immediate treatment response. Furthermore, we have used FD–CT imaging and FD–CT navigation to perform PCA of metastatic lung and bone tumors, as well as cryoneurolysis. However, we have not yet presented either immediate or long-term results of using these new technologies. Aim . To study the immediate and long-term results of using the technology of angiographically-assisted FD–CT-guided PCA of hypovascular liver metastases, kidney tumors and FD–CT-guided PCA of lung metastases. Materials and methods. Between February 2017 and February 2021, 345 sessions of argon-helium PCA were performed in 256 patients: in 216 cases due to liver metastases, in 14 due to kidney tumors, in 7 due to lung metastases, in 19 due to pain syndrome. Results . The technical success of angiographically-assisted FD–CT-controlled PCA was 98.7 % for liver metastases, 92.9 % for kidney tumors, 100 % for lung metastases. The technical success and clinical effectiveness of interventions aimed at treating pain syndrome were 100 %. All complications were grade I–III per the CIRSE (Cardiovascular and Interventional Radiological Society of Europe) classification and were successfully eliminated either directly during the cryoablation procedure or in the early postoperative period. After angiographically-assisted FD–CT-controlled PCA of liver metastases, median overall survival was 37.0 months, 1-, 2-, 3- and 5-year survival rates were, respectively, 93.0, 69.1, 51.7 and 27.9 %; after the procedures for kidney tumors the values were 73.5 months and 100, 100, 100 and 100 %; after the procedures for lung metastases, 26.0 months and 85.7, 71.4, 28.6 and 28.6 %, respectively. Conclusion . The developed technologies of argon-helium PCA under FD–CT control are safe and effective for curative treatment of malignant tumors of the liver, kidneys and lungs, as well as for palliative treatment of bone metastases and cryoneurolysis. To confirm the obtained results and further develop angiographically-assisted FD–CT-guided PCA technologies with their possible inclusion in the standards of medical care, it is necessary to conduct additional large prospective multicenter studies.
- 15 October 2026
- Published by "MedINK" Publishing House in Title
- Vol. 1 (1) , 8-40
Open AccessNew technologies of percutaneous cryoablation of tumors under the control of flat-detector computed tomography: Immediate and long-term results of treatment of 256 patients
Background . Previously, we developed and described two technologies for angiographically-assisted percutaneous argon-helium cryoablation (PCA) of metastatic liver tumors and kidney cancer using flat-detector computed tomography (FD–CT) for visualization, navigation, monitoring, and assessment of the immediate treatment response. Furthermore, we have used FD–CT imaging and FD–CT navigation to perform PCA of metastatic lung and bone tumors, as well as cryoneurolysis. However, we have not yet presented either immediate or long-term results of using these new technologies. Aim . To study the immediate and long-term results of using the technology of angiographically-assisted FD–CT-guided PCA of hypovascular liver metastases, kidney tumors and FD–CT-guided PCA of lung metastases. Materials and methods. Between February 2017 and February 2021, 345 sessions of argon-helium PCA were performed in 256 patients: in 216 cases due to liver metastases, in 14 due to kidney tumors, in 7 due to lung metastases, in 19 due to pain syndrome. Results . The technical success of angiographically-assisted FD–CT-controlled PCA was 98.7 % for liver metastases, 92.9 % for kidney tumors, 100 % for lung metastases. The technical success and clinical effectiveness of interventions aimed at treating pain syndrome were 100 %. All complications were grade I–III per the CIRSE (Cardiovascular and Interventional Radiological Society of Europe) classification and were successfully eliminated either directly during the cryoablation procedure or in the early postoperative period. After angiographically-assisted FD–CT-controlled PCA of liver metastases, median overall survival was 37.0 months, 1-, 2-, 3- and 5-year survival rates were, respectively, 93.0, 69.1, 51.7 and 27.9 %; after the procedures for kidney tumors the values were 73.5 months and 100, 100, 100 and 100 %; after the procedures for lung metastases, 26.0 months and 85.7, 71.4, 28.6 and 28.6 %, respectively. Conclusion . The developed technologies of argon-helium PCA under FD–CT control are safe and effective for curative treatment of malignant tumors of the liver, kidneys and lungs, as well as for palliative treatment of bone metastases and cryoneurolysis. To confirm the obtained results and further develop angiographically-assisted FD–CT-guided PCA technologies with their possible inclusion in the standards of medical care, it is necessary to conduct additional large prospective multicenter studies.
- Open Access
- 21 September 2026
- Published by Australasia Publishing Group in Oncology, Nuclear Medicine and Transplantology
- Vol. 2 (3, Suppl. ) , onmt_A14
Comparison of the Sensitivity of CT-Arteriohepaticography and Intravenous Contrast-Enhanced CT in Colorectal Cancer Liver Metastases After Neoadjuvant Chemotherapy
Introduction: The main method for preoperative assessment of colorectal cancer (CRC) liver metastases remains intravenous contrast-enhanced computed tomography (CT); however, its sensitivity is limited, especially for lesions smaller than 10 mm, and neoadjuvant chemotherapy further reduces it. The characteristic CT appearance of a metastasis is hypodensity in the portal phase and a rim of enhancement at the lesion edge, which can be enhanced by injecting contrast material directly into the hepatic arteries. CT-arteriohepaticography (CT-AHG) is potentially more effective, including during drug treatment, but data on its sensitivity after chemotherapy are virtually absent. Objective: To compare the diagnostic efficacy of CT-AHG and intravenous contrast-enhanced CT in the detection and characterization of CRC liver metastases in patients after neoadjuvant chemotherapy. Materials and Methods: This single-center prospective study included 22 patients with CRC and liver metastases who underwent both imaging methods prior to liver resection at the N.N. Petrov National Medical Research Center of Oncology. The unit of analysis was the lesion. The reference standard was targeted histological examination of each resected lesion. CT and CT-AHG were evaluated independently, using animated images, by radiologists with more than 5 years of experience, one for each "patient–method" pair. For each method, sensitivity, specificity, and predictive values with 95% Clopper–Pearson confidence intervals (CIs) were calculated for 129 included lesions. The difference in sensitivities was reported with 95% CI (patient-level bootstrap) and tested using McNemar's exact test. Results: With combined use of CT and CT-AHG (a lesion was considered positive if detected by at least one method), sensitivity was 80.8% [72.6–87.4], which was 10.0 percentage points (95% CI: +2.4 to +17.9) higher than the sensitivity of CT alone. Individually, sensitivity was 70.8% [61.8–78.8] for CT and 73.3% [64.5–81.0] for CT-AHG. The difference between them was −2.5 percentage points (95% CI: −9.5 to +6.8) and was not statistically significant (p = 0.66). For lesions smaller than 10 mm, sensitivity was 35.3% for CT versus 50.0% for CT-AHG; for lesions 10 mm or larger, sensitivity was 84.9% and 82.6%, respectively. Conclusion: The sensitivity of CT-AHG does not differ significantly from that of intravenous contrast-enhanced CT; however, the combination of methods improves sensitivity by 10.0 percentage points. Therefore, CT-AHG should be considered as a complement to CT, rather than a replacement for it.
- 21 September 2026
- Published by Australasia Publishing Group in Oncology, Nuclear Medicine and Transplantology
- Vol. 2 (3, Suppl. ) , onmt_A14
Open AccessComparison of the Sensitivity of CT-Arteriohepaticography and Intravenous Contrast-Enhanced CT in Colorectal Cancer Liver Metastases After Neoadjuvant Chemotherapy
Introduction: The main method for preoperative assessment of colorectal cancer (CRC) liver metastases remains intravenous contrast-enhanced computed tomography (CT); however, its sensitivity is limited, especially for lesions smaller than 10 mm, and neoadjuvant chemotherapy further reduces it. The characteristic CT appearance of a metastasis is hypodensity in the portal phase and a rim of enhancement at the lesion edge, which can be enhanced by injecting contrast material directly into the hepatic arteries. CT-arteriohepaticography (CT-AHG) is potentially more effective, including during drug treatment, but data on its sensitivity after chemotherapy are virtually absent. Objective: To compare the diagnostic efficacy of CT-AHG and intravenous contrast-enhanced CT in the detection and characterization of CRC liver metastases in patients after neoadjuvant chemotherapy. Materials and Methods: This single-center prospective study included 22 patients with CRC and liver metastases who underwent both imaging methods prior to liver resection at the N.N. Petrov National Medical Research Center of Oncology. The unit of analysis was the lesion. The reference standard was targeted histological examination of each resected lesion. CT and CT-AHG were evaluated independently, using animated images, by radiologists with more than 5 years of experience, one for each "patient–method" pair. For each method, sensitivity, specificity, and predictive values with 95% Clopper–Pearson confidence intervals (CIs) were calculated for 129 included lesions. The difference in sensitivities was reported with 95% CI (patient-level bootstrap) and tested using McNemar's exact test. Results: With combined use of CT and CT-AHG (a lesion was considered positive if detected by at least one method), sensitivity was 80.8% [72.6–87.4], which was 10.0 percentage points (95% CI: +2.4 to +17.9) higher than the sensitivity of CT alone. Individually, sensitivity was 70.8% [61.8–78.8] for CT and 73.3% [64.5–81.0] for CT-AHG. The difference between them was −2.5 percentage points (95% CI: −9.5 to +6.8) and was not statistically significant (p = 0.66). For lesions smaller than 10 mm, sensitivity was 35.3% for CT versus 50.0% for CT-AHG; for lesions 10 mm or larger, sensitivity was 84.9% and 82.6%, respectively. Conclusion: The sensitivity of CT-AHG does not differ significantly from that of intravenous contrast-enhanced CT; however, the combination of methods improves sensitivity by 10.0 percentage points. Therefore, CT-AHG should be considered as a complement to CT, rather than a replacement for it.
- 30 June 2026
- Published by Radiology-Press Publishing House in Журнал "Диагностическая и интервенционная радиология"
- Vol. Том 20 №2 (2) , 38-52
РЕНТГЕНОХИРУРГИЧЕСКИЕ ТЕХНОЛОГИИ В ДИАГНОСТИКЕ И ЛЕЧЕНИИ ЗАБОЛЕВАНИЙ ЛИМФАТИЧЕСКОЙ СИСТЕМЫ: ИСТОРИКО-МЕТОДИЧЕСКИЙ ОБЗОР (ЧАСТЬ II)
В представленной работе подробно проанализированы основные этапы становления и развития рентгенохирургической лимфологии, показывающие как данное направление из полузабытого метода рентгеновской визуализации эволюционировало в 21 веке в новую высокотехнологичную дисциплину с устоявшимися алгоритмами диагностики и лечения, играющую в настоящее время ключевую роль в управлении сложнейшими врожденными рефлюксассоциированными, обструктивными и гипердинамическими лимфатическими аномалиями, а также тяжелыми хирургическими и онкологическими осложнениями, связанными с лимфатической системой. В первой части работы в хронологическом порядке рассмотрены преимущественно диагностические рентегнохирургические технологии, а во второй - различные виды лечебных рентгенохирургических вмешательств. Показано, что появление нового направления рентгенохирургии, специализирующегося на третьем, и долгое время игнорируемом контуре сердечно-сосудистой системы, требует создания в России специализированных рентгенохирургических центров лимфологической компетенции на базе крупных научно-исследовательских онкологических, кардиологических и трансплантационных центров, стандартизации разработанных процедур, введения их в номенклатуру медицинских услуг, а также подготовки соответствующих специалистов. The presented work analyzes in detail the main stages of the formation and development of X-ray surgical lymphology, showing how this direction from a half-forgotten X-ray visualization method evolved in the 21st century into a new high-tech discipline with established diagnostic and treatment algorithms, which currently plays a key role in the management of complex congenital reflux-associated, obstructive, and hyperdynamic lymphatic anomalies, as well as severe surgical and oncological complications associated with the lymphatic system. The first part of the work in chronological order examines primarily diagnostic X-ray surgical technologies, and the second examines various types of therapeutic X-ray surgical interventions. It has been shown that the emergence of a new direction in X-ray surgery, specializing in the third and long-ignored contour of the cardiovascular system, requires the creation in Russia of specialized X-ray surgical centers with lymphological competence on the basis of large research oncology, cardiology, and transplant centers; standardization of the developed procedures; their introduction into the nomenclature of medical services; as well as the training of relevant specialists.
- 30 June 2026
- Published by Radiology-Press Publishing House in Журнал "Диагностическая и интервенционная радиология"
- Vol. Том 20 №2 (2) , 38-52
РЕНТГЕНОХИРУРГИЧЕСКИЕ ТЕХНОЛОГИИ В ДИАГНОСТИКЕ И ЛЕЧЕНИИ ЗАБОЛЕВАНИЙ ЛИМФАТИЧЕСКОЙ СИСТЕМЫ: ИСТОРИКО-МЕТОДИЧЕСКИЙ ОБЗОР (ЧАСТЬ II)
В представленной работе подробно проанализированы основные этапы становления и развития рентгенохирургической лимфологии, показывающие как данное направление из полузабытого метода рентгеновской визуализации эволюционировало в 21 веке в новую высокотехнологичную дисциплину с устоявшимися алгоритмами диагностики и лечения, играющую в настоящее время ключевую роль в управлении сложнейшими врожденными рефлюксассоциированными, обструктивными и гипердинамическими лимфатическими аномалиями, а также тяжелыми хирургическими и онкологическими осложнениями, связанными с лимфатической системой. В первой части работы в хронологическом порядке рассмотрены преимущественно диагностические рентегнохирургические технологии, а во второй - различные виды лечебных рентгенохирургических вмешательств. Показано, что появление нового направления рентгенохирургии, специализирующегося на третьем, и долгое время игнорируемом контуре сердечно-сосудистой системы, требует создания в России специализированных рентгенохирургических центров лимфологической компетенции на базе крупных научно-исследовательских онкологических, кардиологических и трансплантационных центров, стандартизации разработанных процедур, введения их в номенклатуру медицинских услуг, а также подготовки соответствующих специалистов. The presented work analyzes in detail the main stages of the formation and development of X-ray surgical lymphology, showing how this direction from a half-forgotten X-ray visualization method evolved in the 21st century into a new high-tech discipline with established diagnostic and treatment algorithms, which currently plays a key role in the management of complex congenital reflux-associated, obstructive, and hyperdynamic lymphatic anomalies, as well as severe surgical and oncological complications associated with the lymphatic system. The first part of the work in chronological order examines primarily diagnostic X-ray surgical technologies, and the second examines various types of therapeutic X-ray surgical interventions. It has been shown that the emergence of a new direction in X-ray surgery, specializing in the third and long-ignored contour of the cardiovascular system, requires the creation in Russia of specialized X-ray surgical centers with lymphological competence on the basis of large research oncology, cardiology, and transplant centers; standardization of the developed procedures; their introduction into the nomenclature of medical services; as well as the training of relevant specialists.
- 30 June 2026
- Published by Radiology-Press Publishing House in Журнал "Диагностическая и интервенционная радиология"
- Vol. Том 20 №2 (2) , 38-52
РЕНТГЕНОХИРУРГИЧЕСКИЕ ТЕХНОЛОГИИ В ДИАГНОСТИКЕ И ЛЕЧЕНИИ ЗАБОЛЕВАНИЙ ЛИМФАТИЧЕСКОЙ СИСТЕМЫ: ИСТОРИКО-МЕТОДИЧЕСКИЙ ОБЗОР (ЧАСТЬ II)
В представленной работе подробно проанализированы основные этапы становления и развития рентгенохирургической лимфологии, показывающие как данное направление из полузабытого метода рентгеновской визуализации эволюционировало в 21 веке в новую высокотехнологичную дисциплину с устоявшимися алгоритмами диагностики и лечения, играющую в настоящее время ключевую роль в управлении сложнейшими врожденными рефлюксассоциированными, обструктивными и гипердинамическими лимфатическими аномалиями, а также тяжелыми хирургическими и онкологическими осложнениями, связанными с лимфатической системой. В первой части работы в хронологическом порядке рассмотрены преимущественно диагностические рентегнохирургические технологии, а во второй - различные виды лечебных рентгенохирургических вмешательств. Показано, что появление нового направления рентгенохирургии, специализирующегося на третьем, и долгое время игнорируемом контуре сердечно-сосудистой системы, требует создания в России специализированных рентгенохирургических центров лимфологической компетенции на базе крупных научно-исследовательских онкологических, кардиологических и трансплантационных центров, стандартизации разработанных процедур, введения их в номенклатуру медицинских услуг, а также подготовки соответствующих специалистов. The presented work analyzes in detail the main stages of the formation and development of X-ray surgical lymphology, showing how this direction from a half-forgotten X-ray visualization method evolved in the 21st century into a new high-tech discipline with established diagnostic and treatment algorithms, which currently plays a key role in the management of complex congenital reflux-associated, obstructive, and hyperdynamic lymphatic anomalies, as well as severe surgical and oncological complications associated with the lymphatic system. The first part of the work in chronological order examines primarily diagnostic X-ray surgical technologies, and the second examines various types of therapeutic X-ray surgical interventions. It has been shown that the emergence of a new direction in X-ray surgery, specializing in the third and long-ignored contour of the cardiovascular system, requires the creation in Russia of specialized X-ray surgical centers with lymphological competence on the basis of large research oncology, cardiology, and transplant centers; standardization of the developed procedures; their introduction into the nomenclature of medical services; as well as the training of relevant specialists.
- 30 June 2026
- Published by Radiology-Press Publishing House in Журнал "Диагностическая и интервенционная радиология"
- Vol. Том 20 №2 (2) , 38-52
РЕНТГЕНОХИРУРГИЧЕСКИЕ ТЕХНОЛОГИИ В ДИАГНОСТИКЕ И ЛЕЧЕНИИ ЗАБОЛЕВАНИЙ ЛИМФАТИЧЕСКОЙ СИСТЕМЫ: ИСТОРИКО-МЕТОДИЧЕСКИЙ ОБЗОР (ЧАСТЬ II)
В представленной работе подробно проанализированы основные этапы становления и развития рентгенохирургической лимфологии, показывающие как данное направление из полузабытого метода рентгеновской визуализации эволюционировало в 21 веке в новую высокотехнологичную дисциплину с устоявшимися алгоритмами диагностики и лечения, играющую в настоящее время ключевую роль в управлении сложнейшими врожденными рефлюксассоциированными, обструктивными и гипердинамическими лимфатическими аномалиями, а также тяжелыми хирургическими и онкологическими осложнениями, связанными с лимфатической системой. В первой части работы в хронологическом порядке рассмотрены преимущественно диагностические рентегнохирургические технологии, а во второй - различные виды лечебных рентгенохирургических вмешательств. Показано, что появление нового направления рентгенохирургии, специализирующегося на третьем, и долгое время игнорируемом контуре сердечно-сосудистой системы, требует создания в России специализированных рентгенохирургических центров лимфологической компетенции на базе крупных научно-исследовательских онкологических, кардиологических и трансплантационных центров, стандартизации разработанных процедур, введения их в номенклатуру медицинских услуг, а также подготовки соответствующих специалистов. The presented work analyzes in detail the main stages of the formation and development of X-ray surgical lymphology, showing how this direction from a half-forgotten X-ray visualization method evolved in the 21st century into a new high-tech discipline with established diagnostic and treatment algorithms, which currently plays a key role in the management of complex congenital reflux-associated, obstructive, and hyperdynamic lymphatic anomalies, as well as severe surgical and oncological complications associated with the lymphatic system. The first part of the work in chronological order examines primarily diagnostic X-ray surgical technologies, and the second examines various types of therapeutic X-ray surgical interventions. It has been shown that the emergence of a new direction in X-ray surgery, specializing in the third and long-ignored contour of the cardiovascular system, requires the creation in Russia of specialized X-ray surgical centers with lymphological competence on the basis of large research oncology, cardiology, and transplant centers; standardization of the developed procedures; their introduction into the nomenclature of medical services; as well as the training of relevant specialists.
- 14 June 2026
- Published by Non-profit partnership Society of Interventional Oncoradiologists in Journal of oncology: diagnostic radiology and radiotherapy
- Vol. 9 (2)
Flat-Detector Computed Tomography Technologies in Neuro-Oncology: The Experience of the N.N. Petrov National Medical Research Center of Oncology
Relevance : The growing burden of central nervous system tumors increases the need for accurate and minimally invasive intraoperative imaging and navigation technologies. Flat-detector computed tomography (FDCT) provides volumetric and crossectional CT-imaging directly in the angiography suite and can be integrated with fluoroscopy and navigation. Purpose : To assess the capabilities and principal applications of flat-detector computed tomography in neuro-oncology based on the experience of a single tertiary cancer center. Materials and methods : A single-center retrospective descriptive analysis included 207 interventional procedures performed in 207 patients at the N.N. Petrov National Medical Research Center of Oncology from November 2021 to December 2025. Procedures were carried out using an Artis Zee Floor angiographic system (Siemens). Statistical analysis was performed with Microsoft Excel 2016 and STATISTICA 12. Results : The median patient age was 58 years (45; 69); 95 patients were men and 112 were women. FDCT was used for stereotactic brain tumor biopsy (n = 159), diagnostic cerebral angiography (n = 14), drainage of tumor cysts (n = 11), Ommaya reservoir implantation (n = 7), ventriculoperitoneal shunting (n = 6), vertebroplasty (n = 5), drainage of brain abscesses (n = 3), and preoperative meningioma embolization (n = 2). The technology provided real-time intraoperative three-dimensional visualization, navigation planning, instrument position control, and immediate assessment of procedural results. The most convincing advantages were observed in stereotactic brain tumor biopsy. Conclusions : FDCT is a promising universal intraoperative platform for minimally invasive neuro-oncological procedures. Its use may improve procedural accuracy, controllability, and safety, with the strongest current rationale seen for stereotactic brain tumor biopsy.
- 14 June 2026
- Published by Non-profit partnership Society of Interventional Oncoradiologists in Journal of oncology: diagnostic radiology and radiotherapy
- Vol. 9 (2)
Flat-Detector Computed Tomography Technologies in Neuro-Oncology: The Experience of the N.N. Petrov National Medical Research Center of Oncology
Relevance : The growing burden of central nervous system tumors increases the need for accurate and minimally invasive intraoperative imaging and navigation technologies. Flat-detector computed tomography (FDCT) provides volumetric and crossectional CT-imaging directly in the angiography suite and can be integrated with fluoroscopy and navigation. Purpose : To assess the capabilities and principal applications of flat-detector computed tomography in neuro-oncology based on the experience of a single tertiary cancer center. Materials and methods : A single-center retrospective descriptive analysis included 207 interventional procedures performed in 207 patients at the N.N. Petrov National Medical Research Center of Oncology from November 2021 to December 2025. Procedures were carried out using an Artis Zee Floor angiographic system (Siemens). Statistical analysis was performed with Microsoft Excel 2016 and STATISTICA 12. Results : The median patient age was 58 years (45; 69); 95 patients were men and 112 were women. FDCT was used for stereotactic brain tumor biopsy (n = 159), diagnostic cerebral angiography (n = 14), drainage of tumor cysts (n = 11), Ommaya reservoir implantation (n = 7), ventriculoperitoneal shunting (n = 6), vertebroplasty (n = 5), drainage of brain abscesses (n = 3), and preoperative meningioma embolization (n = 2). The technology provided real-time intraoperative three-dimensional visualization, navigation planning, instrument position control, and immediate assessment of procedural results. The most convincing advantages were observed in stereotactic brain tumor biopsy. Conclusions : FDCT is a promising universal intraoperative platform for minimally invasive neuro-oncological procedures. Its use may improve procedural accuracy, controllability, and safety, with the strongest current rationale seen for stereotactic brain tumor biopsy.
- 30 March 2026
- Published by Radiology-Press Publishing House in Журнал "Диагностическая и интервенционная радиология"
- Vol. Том 20 №1 (1) , 14-25
РЕНТГЕНОХИРУРГИЧЕСКИЕ ТЕХНОЛОГИИ В ДИАГНОСТИКЕ И ЛЕЧЕНИИ ЗАБОЛЕВАНИЙ ЛИМФАТИЧЕСКОЙ СИСТЕМЫ: ИСТОРИКО-МЕТОДИЧЕСКИЙ ОБЗОР (ЧАСТЬ I)
В представленной работе подробно проанализированы основные этапы становления и развития рентгенохирургической лимфологии, показывающие как данное направление из полузабытого метода рентгеновской визуализации эволюционировало в 21 веке в новую высокотехнологичную дисциплину с устоявшимися алгоритмами диагностики и лечения, играющую в настоящее время ключевую роль в управлении сложнейшими врожденными рефлюксассоциированными, обструктивными и гипердинамическими лимфатическими аномалиями, а также тяжелыми хирургическими и онкологическими осложнениями, связанными с лимфатической системой. В первой части работы в хронологическом порядке рассмотрены преимущественно диагностические рентегнохирургические технологии, а во второй - различные виды лечебных рентгенохирургических вмешательств. Показано, что появление нового направления рентгенохирургии, специализирующегося на третьем, и долгое время игнорируемом контуре сердечно-сосудистой системы, требует создания в России специализированных рентгенохирургических центров лимфологической компетенции на базе крупных научно-исследовательских онкологических, кардиологических и трансплантационных центров, стандартизации разработанных процедур, введения их в номенклатуру медицинских услуг, а также подготовки соответствующих специалистов. The presented work analyzes in detail the main stages of the formation and development of X-ray surgical lymphology, showing how this direction from a half-forgotten X-ray visualization method evolved in the 21st century into a new high-tech discipline with established diagnostic and treatment algorithms, which currently plays a key role in the management of complex congenital reflux-associated, obstructive, and hyperdynamic lymphatic anomalies, as well as severe surgical and oncological complications associated with the lymphatic system. The first part of the work in chronological order examines primarily diagnostic X-ray surgical technologies, and the second - various types of therapeutic X-ray surgical interventions. It has been shown that the emergence of a new direction in X-ray surgery, specializing in the third and long-ignored contour of the cardiovascular system, requires the creation in Russia of specialized X-ray surgical centers with lymphological competence on the basis of large scientific-research oncology, cardiology, and transplant centers; standardization of the developed procedures; their introduction into the nomenclature of medical services; as well as the training of relevant specialists.
- 30 March 2026
- Published by Radiology-Press Publishing House in Журнал "Диагностическая и интервенционная радиология"
- Vol. Том 20 №1 (1) , 14-25
РЕНТГЕНОХИРУРГИЧЕСКИЕ ТЕХНОЛОГИИ В ДИАГНОСТИКЕ И ЛЕЧЕНИИ ЗАБОЛЕВАНИЙ ЛИМФАТИЧЕСКОЙ СИСТЕМЫ: ИСТОРИКО-МЕТОДИЧЕСКИЙ ОБЗОР (ЧАСТЬ I)
В представленной работе подробно проанализированы основные этапы становления и развития рентгенохирургической лимфологии, показывающие как данное направление из полузабытого метода рентгеновской визуализации эволюционировало в 21 веке в новую высокотехнологичную дисциплину с устоявшимися алгоритмами диагностики и лечения, играющую в настоящее время ключевую роль в управлении сложнейшими врожденными рефлюксассоциированными, обструктивными и гипердинамическими лимфатическими аномалиями, а также тяжелыми хирургическими и онкологическими осложнениями, связанными с лимфатической системой. В первой части работы в хронологическом порядке рассмотрены преимущественно диагностические рентегнохирургические технологии, а во второй - различные виды лечебных рентгенохирургических вмешательств. Показано, что появление нового направления рентгенохирургии, специализирующегося на третьем, и долгое время игнорируемом контуре сердечно-сосудистой системы, требует создания в России специализированных рентгенохирургических центров лимфологической компетенции на базе крупных научно-исследовательских онкологических, кардиологических и трансплантационных центров, стандартизации разработанных процедур, введения их в номенклатуру медицинских услуг, а также подготовки соответствующих специалистов. The presented work analyzes in detail the main stages of the formation and development of X-ray surgical lymphology, showing how this direction from a half-forgotten X-ray visualization method evolved in the 21st century into a new high-tech discipline with established diagnostic and treatment algorithms, which currently plays a key role in the management of complex congenital reflux-associated, obstructive, and hyperdynamic lymphatic anomalies, as well as severe surgical and oncological complications associated with the lymphatic system. The first part of the work in chronological order examines primarily diagnostic X-ray surgical technologies, and the second - various types of therapeutic X-ray surgical interventions. It has been shown that the emergence of a new direction in X-ray surgery, specializing in the third and long-ignored contour of the cardiovascular system, requires the creation in Russia of specialized X-ray surgical centers with lymphological competence on the basis of large scientific-research oncology, cardiology, and transplant centers; standardization of the developed procedures; their introduction into the nomenclature of medical services; as well as the training of relevant specialists.
- 30 March 2026
- Published by Radiology-Press Publishing House in Журнал "Диагностическая и интервенционная радиология"
- Vol. Том 20 №1 (1) , 14-25
РЕНТГЕНОХИРУРГИЧЕСКИЕ ТЕХНОЛОГИИ В ДИАГНОСТИКЕ И ЛЕЧЕНИИ ЗАБОЛЕВАНИЙ ЛИМФАТИЧЕСКОЙ СИСТЕМЫ: ИСТОРИКО-МЕТОДИЧЕСКИЙ ОБЗОР (ЧАСТЬ I)
В представленной работе подробно проанализированы основные этапы становления и развития рентгенохирургической лимфологии, показывающие как данное направление из полузабытого метода рентгеновской визуализации эволюционировало в 21 веке в новую высокотехнологичную дисциплину с устоявшимися алгоритмами диагностики и лечения, играющую в настоящее время ключевую роль в управлении сложнейшими врожденными рефлюксассоциированными, обструктивными и гипердинамическими лимфатическими аномалиями, а также тяжелыми хирургическими и онкологическими осложнениями, связанными с лимфатической системой. В первой части работы в хронологическом порядке рассмотрены преимущественно диагностические рентегнохирургические технологии, а во второй - различные виды лечебных рентгенохирургических вмешательств. Показано, что появление нового направления рентгенохирургии, специализирующегося на третьем, и долгое время игнорируемом контуре сердечно-сосудистой системы, требует создания в России специализированных рентгенохирургических центров лимфологической компетенции на базе крупных научно-исследовательских онкологических, кардиологических и трансплантационных центров, стандартизации разработанных процедур, введения их в номенклатуру медицинских услуг, а также подготовки соответствующих специалистов. The presented work analyzes in detail the main stages of the formation and development of X-ray surgical lymphology, showing how this direction from a half-forgotten X-ray visualization method evolved in the 21st century into a new high-tech discipline with established diagnostic and treatment algorithms, which currently plays a key role in the management of complex congenital reflux-associated, obstructive, and hyperdynamic lymphatic anomalies, as well as severe surgical and oncological complications associated with the lymphatic system. The first part of the work in chronological order examines primarily diagnostic X-ray surgical technologies, and the second - various types of therapeutic X-ray surgical interventions. It has been shown that the emergence of a new direction in X-ray surgery, specializing in the third and long-ignored contour of the cardiovascular system, requires the creation in Russia of specialized X-ray surgical centers with lymphological competence on the basis of large scientific-research oncology, cardiology, and transplant centers; standardization of the developed procedures; their introduction into the nomenclature of medical services; as well as the training of relevant specialists.
- 30 March 2026
- Published by Radiology-Press Publishing House in Журнал "Диагностическая и интервенционная радиология"
- Vol. Том 20 №1 (1) , 14-25
РЕНТГЕНОХИРУРГИЧЕСКИЕ ТЕХНОЛОГИИ В ДИАГНОСТИКЕ И ЛЕЧЕНИИ ЗАБОЛЕВАНИЙ ЛИМФАТИЧЕСКОЙ СИСТЕМЫ: ИСТОРИКО-МЕТОДИЧЕСКИЙ ОБЗОР (ЧАСТЬ I)
В представленной работе подробно проанализированы основные этапы становления и развития рентгенохирургической лимфологии, показывающие как данное направление из полузабытого метода рентгеновской визуализации эволюционировало в 21 веке в новую высокотехнологичную дисциплину с устоявшимися алгоритмами диагностики и лечения, играющую в настоящее время ключевую роль в управлении сложнейшими врожденными рефлюксассоциированными, обструктивными и гипердинамическими лимфатическими аномалиями, а также тяжелыми хирургическими и онкологическими осложнениями, связанными с лимфатической системой. В первой части работы в хронологическом порядке рассмотрены преимущественно диагностические рентегнохирургические технологии, а во второй - различные виды лечебных рентгенохирургических вмешательств. Показано, что появление нового направления рентгенохирургии, специализирующегося на третьем, и долгое время игнорируемом контуре сердечно-сосудистой системы, требует создания в России специализированных рентгенохирургических центров лимфологической компетенции на базе крупных научно-исследовательских онкологических, кардиологических и трансплантационных центров, стандартизации разработанных процедур, введения их в номенклатуру медицинских услуг, а также подготовки соответствующих специалистов. The presented work analyzes in detail the main stages of the formation and development of X-ray surgical lymphology, showing how this direction from a half-forgotten X-ray visualization method evolved in the 21st century into a new high-tech discipline with established diagnostic and treatment algorithms, which currently plays a key role in the management of complex congenital reflux-associated, obstructive, and hyperdynamic lymphatic anomalies, as well as severe surgical and oncological complications associated with the lymphatic system. The first part of the work in chronological order examines primarily diagnostic X-ray surgical technologies, and the second - various types of therapeutic X-ray surgical interventions. It has been shown that the emergence of a new direction in X-ray surgery, specializing in the third and long-ignored contour of the cardiovascular system, requires the creation in Russia of specialized X-ray surgical centers with lymphological competence on the basis of large scientific-research oncology, cardiology, and transplant centers; standardization of the developed procedures; their introduction into the nomenclature of medical services; as well as the training of relevant specialists.
- Open Access
- 13 July 2025
- Published by Association of Oncologist Real Clinical Practice OncoPractitioner in Clinical Case in Oncology
- Vol. 3 (1) , 53-61
Collateral blood flow and parasitic blood supply to the tumor as a possible cause of ineffectiveness of transarterial chemoembolization in the treatment of hepatocellular cancer
A clinical case of ineffectiveness of four-fold transarterial chemoembolization of hepatocellular carcinoma is presented, which was caused by the formation of parasitic blood supply to the tumor from extrahepatic sources.
- 13 July 2025
- Published by Association of Oncologist Real Clinical Practice OncoPractitioner in Clinical Case in Oncology
- Vol. 3 (1) , 53-61
Open AccessCollateral blood flow and parasitic blood supply to the tumor as a possible cause of ineffectiveness of transarterial chemoembolization in the treatment of hepatocellular cancer
A clinical case of ineffectiveness of four-fold transarterial chemoembolization of hepatocellular carcinoma is presented, which was caused by the formation of parasitic blood supply to the tumor from extrahepatic sources.
- Open Access
- 17 May 2025
- Published by Tomsk Cancer Research Institute in Siberian journal of oncology
- Vol. 24 (2) , 150-161
Role of embolization in surgery for skull base tumors
Objective: to summarize global and personal experience in the application of embolization techniques in the surgical management of benign and malignant skull base tumors, comprehensively analyzing associated risks and complications to improve treatment approaches and minimize negative outcomes. Material and Methods. An analysis of scientific publications from international medical databases (PubMed, Cochrane Library, Elibrary and others) covering studies over the past 20 years, as well as a retrospective analysis of our own clinical data on embolization for skull base tumors was conducted. Specific details and features of embolization techniques, materials used, and criteria for complication assessment, including classifications developed by international expert societies, were thoroughly examined. Results. The analysis revealed that outcomes from embolization techniques in skull base tumor surgery remain controversial, with a wide range of complications from minor reactions to severe and disabling conditions. Major complications identified included stroke, cranial nerve dysfunction, tissue necrosis, and death. Determination of the optimal timing interval between embolization and subsequent surgical resection is critical, as premature surgery does not fully exploit embolization potential, whereas delayed surgery increases the risk of recanalization and progression of perifocal edema, exacerbating neurological deficits. Particular attention was given to the postembolization neurological syndrome (PENS), which may result in persistent and irreversible neurological impairment. Conclusion. Despite potential benefits in reducing intraoperative blood loss and facilitating surgical procedures, the use of embolization technologies requires careful evaluation of risks and potential complications. Decisions regarding embolization should be individualized and based on a multidisciplinary approach considering the specifics of each clinical case.
- 17 May 2025
- Published by Tomsk Cancer Research Institute in Siberian journal of oncology
- Vol. 24 (2) , 150-161
Open AccessRole of embolization in surgery for skull base tumors
Objective: to summarize global and personal experience in the application of embolization techniques in the surgical management of benign and malignant skull base tumors, comprehensively analyzing associated risks and complications to improve treatment approaches and minimize negative outcomes. Material and Methods. An analysis of scientific publications from international medical databases (PubMed, Cochrane Library, Elibrary and others) covering studies over the past 20 years, as well as a retrospective analysis of our own clinical data on embolization for skull base tumors was conducted. Specific details and features of embolization techniques, materials used, and criteria for complication assessment, including classifications developed by international expert societies, were thoroughly examined. Results. The analysis revealed that outcomes from embolization techniques in skull base tumor surgery remain controversial, with a wide range of complications from minor reactions to severe and disabling conditions. Major complications identified included stroke, cranial nerve dysfunction, tissue necrosis, and death. Determination of the optimal timing interval between embolization and subsequent surgical resection is critical, as premature surgery does not fully exploit embolization potential, whereas delayed surgery increases the risk of recanalization and progression of perifocal edema, exacerbating neurological deficits. Particular attention was given to the postembolization neurological syndrome (PENS), which may result in persistent and irreversible neurological impairment. Conclusion. Despite potential benefits in reducing intraoperative blood loss and facilitating surgical procedures, the use of embolization technologies requires careful evaluation of risks and potential complications. Decisions regarding embolization should be individualized and based on a multidisciplinary approach considering the specifics of each clinical case.
- Open Access
- 14 April 2025
- Published by Baltic Medical Education Center in Diagnostic radiology and radiotherapy
- Vol. 16 (1) , 126-138
Flat-detector computed tomographic СО2 arteriohepaticography guided liver biopsy in patient with liver tumor and advanced chronic renal failure: a clinical case
INTRODUCTION: Carbon dioxide (СО2) is a safe contrast agent for patients requiring endovascular and angiography-assisted procedures due to lack of renal toxicity and allergic potential. It is highly important in patients with renal failure and allergies to iodinated contrast agents.OBJECTIVE: To demonstrate a clinical case of percutaneous biopsy guided with the flat-detector computed tomography (FDCT) CO2 arteriohepaticography in the patient with suspected metastatic lesion of the liver, history of cervical squamous cell carcinoma and chronic kidney disease (CKD).MATERIALS AND METHODS: A patient with squamous cell carcinoma of the cervix, due to concomitant kidney pathology (chronic tubulointerstitial nephritis, gouty nephropathy, CKD C4 according to the KDIGO classification) has contraindications for iodinated contrast, hence contrast enhanced computed tomography (CT) and regular FDCT angiography. A native CT study revealed a hypodence 17 mm diameter lesion in SVII of the liver. US and MRI data were ambiguous. The presence of a clear hypervascular rim in the arterial and venous phases of dynamic contrast enhancement could not rule out the metastasis. In order to clarify the nature of the lesion in the liver, multidisciplinary team suggested biopsy under digital subtraction angiography and FDCT arteriohepaticography using CO2 as a contrast agent because of the risk of the haemorrage. For this purpose, using the Seldinger technique, through right femoral artery, by means of an Artis Zee angiographic unit (Siemens, Germany) catheterization and gas subtraction angiography of the common hepatic artery were performed. FDCT-CO2-arteriohepaticography of the common hepatic artery was performed afterwards using the same installation and injecting 30 ml of carbon dioxide at the rate of 3 ml/sec (special «Angiodroid» (Italy) CO2 injector was used) and a scanning delay of 3 sec (in 6sDCT Body mode).RESULTS: Вy means of subtraction CO2-arteriohepaticography and FDCT arteriohepaticography using CO2 in SVII of the liver the solitary hypervascular 15 mm lesion was detected. In order to verify the lesion single-shot US and FDCT-guided biopsy was performed. It was followed by a control FDCT arteriohepaticography using CO2 to exclude bleeding. Histopathology refuted metastasis.CONCLUSION: CO2 is a safe contrast agent in patients with renal failure and allergies to iodinated contrast agents. FDCT CO2 arteriohepaticography is an effective alternative method, that allows safe visualization and bleeding control after interventions in patient with renal failure.
- 14 April 2025
- Published by Baltic Medical Education Center in Diagnostic radiology and radiotherapy
- Vol. 16 (1) , 126-138
Open AccessFlat-detector computed tomographic СО2 arteriohepaticography guided liver biopsy in patient with liver tumor and advanced chronic renal failure: a clinical case
INTRODUCTION: Carbon dioxide (СО2) is a safe contrast agent for patients requiring endovascular and angiography-assisted procedures due to lack of renal toxicity and allergic potential. It is highly important in patients with renal failure and allergies to iodinated contrast agents.OBJECTIVE: To demonstrate a clinical case of percutaneous biopsy guided with the flat-detector computed tomography (FDCT) CO2 arteriohepaticography in the patient with suspected metastatic lesion of the liver, history of cervical squamous cell carcinoma and chronic kidney disease (CKD).MATERIALS AND METHODS: A patient with squamous cell carcinoma of the cervix, due to concomitant kidney pathology (chronic tubulointerstitial nephritis, gouty nephropathy, CKD C4 according to the KDIGO classification) has contraindications for iodinated contrast, hence contrast enhanced computed tomography (CT) and regular FDCT angiography. A native CT study revealed a hypodence 17 mm diameter lesion in SVII of the liver. US and MRI data were ambiguous. The presence of a clear hypervascular rim in the arterial and venous phases of dynamic contrast enhancement could not rule out the metastasis. In order to clarify the nature of the lesion in the liver, multidisciplinary team suggested biopsy under digital subtraction angiography and FDCT arteriohepaticography using CO2 as a contrast agent because of the risk of the haemorrage. For this purpose, using the Seldinger technique, through right femoral artery, by means of an Artis Zee angiographic unit (Siemens, Germany) catheterization and gas subtraction angiography of the common hepatic artery were performed. FDCT-CO2-arteriohepaticography of the common hepatic artery was performed afterwards using the same installation and injecting 30 ml of carbon dioxide at the rate of 3 ml/sec (special «Angiodroid» (Italy) CO2 injector was used) and a scanning delay of 3 sec (in 6sDCT Body mode).RESULTS: Вy means of subtraction CO2-arteriohepaticography and FDCT arteriohepaticography using CO2 in SVII of the liver the solitary hypervascular 15 mm lesion was detected. In order to verify the lesion single-shot US and FDCT-guided biopsy was performed. It was followed by a control FDCT arteriohepaticography using CO2 to exclude bleeding. Histopathology refuted metastasis.CONCLUSION: CO2 is a safe contrast agent in patients with renal failure and allergies to iodinated contrast agents. FDCT CO2 arteriohepaticography is an effective alternative method, that allows safe visualization and bleeding control after interventions in patient with renal failure.